Scotia Capital Inc. lifted its position in shares of Aetna Inc (NYSE:AET) by 192.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 26,048 shares of the company’s stock after acquiring an additional 17,140 shares during the period. Scotia Capital Inc.’s holdings in Aetna were worth $4,699,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently modified their holdings of AET. Alpine Associates Management Inc. bought a new position in Aetna in the 4th quarter valued at approximately $159,933,000. Amundi Pioneer Asset Management Inc. lifted its stake in Aetna by 1,087.9% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 926,948 shares of the company’s stock valued at $167,213,000 after purchasing an additional 848,913 shares during the last quarter. Hudson Bay Capital Management LP lifted its stake in Aetna by 462.4% in the 4th quarter. Hudson Bay Capital Management LP now owns 845,810 shares of the company’s stock valued at $152,576,000 after purchasing an additional 695,428 shares during the last quarter. Orbimed Advisors LLC lifted its stake in Aetna by 57.3% in the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock valued at $222,057,000 after purchasing an additional 508,600 shares during the last quarter. Finally, CI Investments Inc. acquired a new position in Aetna in the 4th quarter valued at approximately $87,552,000. 87.34% of the stock is owned by institutional investors and hedge funds.
Aetna Inc (AET) traded down $0.91 during trading on Wednesday, hitting $176.53. 1,368,943 shares of the company’s stock were exchanged, compared to its average volume of 2,563,194. Aetna Inc has a 12-month low of $124.84 and a 12-month high of $194.40. The company has a market capitalization of $57,891.71, a price-to-earnings ratio of 30.78, a price-to-earnings-growth ratio of 1.43 and a beta of 0.65. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.65 and a quick ratio of 0.65.
Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The firm had revenue of $14.74 billion for the quarter, compared to analyst estimates of $14.79 billion. During the same period last year, the firm earned $0.08 earnings per share. The business’s quarterly revenue was down 6.2% compared to the same quarter last year. sell-side analysts forecast that Aetna Inc will post 11.06 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, April 12th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Wednesday, April 11th. Aetna’s dividend payout ratio (DPR) is 34.78%.
Several brokerages have issued reports on AET. Piper Jaffray Companies upgraded shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target for the company in a research report on Wednesday, January 3rd. Wells Fargo & Co restated an “outperform” rating and issued a $208.00 price target (up from $200.00) on shares of Aetna in a research report on Monday, December 4th. Morgan Stanley cut shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price target for the company. in a research report on Wednesday, December 20th. Deutsche Bank upgraded shares of Aetna from a “hold” rating to a “buy” rating and upped their price target for the company from $195.00 to $212.00 in a research report on Monday, January 22nd. Finally, ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Nine analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Aetna has a consensus rating of “Buy” and an average target price of $189.50.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.